4.7 Article

A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer

Journal

GENES & DEVELOPMENT
Volume 20, Issue 18, Pages 2513-2526

Publisher

COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
DOI: 10.1101/gad.1446006

Keywords

breast cancer; estrogen receptor; cyclin D1; transcription; enhancer; chromatin

Funding

  1. NCI NIH HHS [P01 CA080111, P01 CA80111] Funding Source: Medline
  2. NIDDK NIH HHS [R56 DK074967] Funding Source: Medline

Ask authors/readers for more resources

Estrogen stimulates the proliferation of the most common type of human breast cancer that expresses estrogen receptor alpha(ER alpha) through the activation of the cyclin D1 (CCND1) oncogene. However, our knowledge of ER alpha transcriptional mechanisms remains limited. Hence, it is still elusive why ER alpha ectopically expressed in ER-negative breast cancer cells (BCC) is functional on ectopic reporter constructs but lacks activity on many endogenous target genes, including CCND1. Here, we show that estradiol (E2) stimulation of CCND1 expression in BCC depends on a novel cell-type-specific enhancer downstream from the CCND1 coding region, which is the primary ER alpha recruitment site in estrogen-responsive cells. The pioneer factor FoxA1 is specifically required for the active chromatin state of this enhancer and as such is crucial for both CCND1 expression and subsequent cell cycle progression. Interestingly, even in BCC, CCND1 levels and proliferation are tightly controlled by E2 through the establishment of a negative feedforward loop involving the induction of NFIC, a putative tumor suppressor capable of directly repressing CCND1 transcription. Taken together, our results reveal an estrogen-regulated combinatorial network including cell-specific cis- and trans-regulators of CCND1 expression where ER alpha collaborates with other transcription factors associated with the ER-positive breast cancer phenotype, including FoxA1 and NFIC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available